跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
曾 炳輝
副教授
生化暨分子生物研究所
電話
886-2-2826-7234
電子郵件
phtseng
nycu.edu
tw
h-index
h10-index
h5-index
3587
引文
24
h-指數
按照存儲在普爾(Pure)的出版物數量及斯高帕斯(Scopus)引文計算。
326
引文
11
h-指數
按照存儲在普爾(Pure)的出版物數量及斯高帕斯(Scopus)引文計算。
89
引文
4
h-指數
按照存儲在普爾(Pure)的出版物數量及斯高帕斯(Scopus)引文計算。
1997 …
2024
每年研究成果
概覽
指紋
網路
研究成果
(37)
類似的個人檔案
(6)
指紋
查看啟用 Ping-Hui Tseng 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Toll-like
100%
Celecoxib
79%
PDK1
74%
Hepatocellular Carcinoma
66%
TRAF3
64%
Prostate Cancer Cells
58%
Hepatocellular Carcinoma Cells
53%
SHP-1
53%
Cyclooxygenase-2
43%
SC-2001
41%
Ubiquitination
39%
Obatoclax
38%
Macrophages
37%
Polyubiquitination
35%
Cyclooxygenase-2 Inhibitors
35%
Solid-phase Synthesis
35%
Immune Response
35%
CpG ODN
35%
Induced Apoptosis
34%
TNF Receptor 1 (TNFR1)
32%
Apoptosis
32%
OSU-03012
31%
AKT Pathway
31%
Mitogen-activated Protein Kinase
31%
Inflammation
29%
TRAF2
29%
NF-B
28%
Family Members
28%
Adaptor
26%
Inflammatory Cytokines
26%
Signaling Mechanism
25%
Lysine
23%
GalNAc
23%
Cell Growth
23%
Liver Cancer
22%
Tumor Necrosis Factor-α
22%
Nuclear factor-B
22%
Type I Interferon
22%
Kinase Activation
22%
Functional Groups
22%
Interleukin-1β
22%
Inflammatory Response
21%
Sorafenib
21%
Liver
21%
Interleukin-6
21%
Growth Inhibition
20%
Phosphoinositide 3-kinase (PI3K)
20%
G1 Arrest
19%
In Cancer
19%
Transforming Growth Factor-β
19%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
63%
Celecoxib
61%
Phosphoinositide-Dependent Kinase-1
56%
Phosphotransferase
53%
Kinase
53%
Ubiquitination
48%
Cyclooxygenase
38%
TLR4
35%
Mitogen-Activated Protein Kinase
35%
TRAF2
35%
TRAF3
35%
COX-2 Inhibitor
35%
Lysine
35%
Signaling Mechanism
28%
Secretion (Process)
25%
Cell Growth
23%
Akt Signaling
22%
Phosphoinositide 3-Kinase
21%
Lipopolysaccharide
21%
G1/S Transition
19%
P38 Mitogen-Activated Protein Kinases
19%
P53
19%
Cancer Growth Factor
19%
Bcl-xL
17%
Caspase 1
17%
NOD2
17%
Asialoglycoprotein Receptor
17%
USP7
17%
Cytokine Receptor
17%
Synapsin I
17%
Positive Feedback
17%
TRPC6
17%
Inhibitor of Apoptosis
17%
Glycoside
17%
Hedgehog Signaling Pathway
17%
MicroRNA
17%
Dipole
17%
Monoclonal Antibody
17%
Autoregulation
17%
Solid Phase Synthesis
17%
Phosphatidylinositol (3,4,5)-trisphosphate
17%
Receptor Potential
17%
Complement Factor B
17%
Interleukin-1
17%
Protein Phosphatase 1
17%
Histone Acetylation
17%
Dexamethasone
17%
Histone Deacetylase
17%
Imatinib
17%
Bacillus Anthracis
17%
Immunology and Microbiology
Cancer Cell
58%
Toll-Like Receptor
44%
Immune Response
39%
Macrophage
39%
Tumor Necrosis Factor
36%
Ubiquitination
35%
TLR4
35%
TRAF3
35%
TLR9
35%
CpG Oligodeoxynucleotide
35%
Akt Signaling
34%
Tumor Necrosis Factor Receptor
30%
Secretion (Process)
29%
IC50
28%
Inflammation Response
26%
Interleukin-1
26%
Interleukin 6
25%
Proinflammatory Cytokine
23%
G1 Phase Cell Cycle Checkpoint
23%
Immunity
22%
Upregulation
21%
Chemokine
18%
Cytokine
18%
Carcinoma Cell
18%
Cell Growth
18%
B Cell Activating Factor
17%
NOD2
17%
Bacillus Anthracis
17%
Muramyl Dipeptide
17%
Neutrophil
17%
Knockout Mouse
17%
Dexamethasone
17%
Positive Feedback
17%
Virus Oncogene
17%
Receptor Potential
17%
Oncogene C Myc
17%
Mycobacterium Tuberculosis
17%
T Cell
17%
Prostaglandin F2
17%
Prostaglandin F2 Alpha
17%
Trastuzumab
17%
Monoclonal Antibody
17%
Leporidae
17%
Umbilical Vein Endothelial Cell
17%
TLR2
17%
Cell Death
17%
Signaling Mechanism
17%
Caspase 1
17%
interferon
17%
Innate Immune System
14%